VALSARTAN ( DrugBank: Valsartan )


7 diseases
IDDisease name (Link within this page)Number of trials
57Idiopathic dilated cardiomyopathy1
58Hypertrophic cardiomyopathy10
66IgA nephropathy7
75Cushing disease1
218Alport syndrome1
222Primary nephrotic syndrome5
224Purpura nephritis3

57. Idiopathic dilated cardiomyopathy


Clinical trials : 11Drugs : 23 - (DrugBank : 12) / Drug target genes : 9 - Drug target pathways : 35 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

58. Hypertrophic cardiomyopathy


Clinical trials : 126Drugs : 135 - (DrugBank : 42) / Drug target genes : 46 - Drug target pathways : 162 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

66. IgA nephropathy


Clinical trials : 275Drugs : 258 - (DrugBank : 82) / Drug target genes : 36 - Drug target pathways : 140 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

75. Cushing disease


Clinical trials : 205Drugs : 176 - (DrugBank : 45) / Drug target genes : 61 - Drug target pathways : 127 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

218. Alport syndrome


Clinical trials : 30Drugs : 36 - (DrugBank : 15) / Drug target genes : 8 - Drug target pathways : 46 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

222. Primary nephrotic syndrome


Clinical trials : 310Drugs : 295 - (DrugBank : 117) / Drug target genes : 63 - Drug target pathways : 194 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

224. Purpura nephritis


Clinical trials : 16Drugs : 43 - (DrugBank : 21) / Drug target genes : 15 - Drug target pathways : 58 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries